J&J vaccine rollout to resume in Europe with blood clot warnings
Published
The company has also reportedly agreed to work with a German scientist studying extremely rare blood clots linked to AstraZeneca’s COVID-19 vaccine.
Full ArticlePublished
The company has also reportedly agreed to work with a German scientist studying extremely rare blood clots linked to AstraZeneca’s COVID-19 vaccine.
Full ArticleWith the U.S. pause of Johnson & Johnson’s COVID-19 vaccine stretched into a second week, authorities are weighing whether to..
“I am not going to be talking about numbers today,” Australia’s Chief Medical Officer Paul Kelly told Australia’s Radio..